Symmetry Technologies Inc. moves to lab test and develop its "Inducible Expression System for Biosynthetic Production of Test...
October 07 2013 - 7:00AM
Symmetry Technologies Inc. (SMMR). is pleased to announce that it
has initiated contact with a US based BioScience research and
testing facility in its efforts to further develop the Company's
"Inducible Expression System for Biosynthetic Production of
Testosterone in Men"
"We believe that we are on the right track in order to realize
the full potential of this proprietary technology" says President
Chad Reed who further states that "Additional details in regards to
testing and development will be released as they become
available"
About The Company:
The Company is in the business of creating, licensing and
marketing nutraceutical products and is developing a proprietary
human rejuvenation nutriceutical with the help of a small group of
PhD molecular biologists. Symmetry believes that by isolating
certain compounds, the effects will be inducement of apoptosis in
senescent cells, stimulation of stem cell growth, and the
suppression of herpes activity. The Company believes that by
clearing tissues with short average telomere length and stimulating
longer telomere cell growth, including differentiation from stem
cell populations, while ameliorating the effects of HSV activity,
they will produce an effect that is tantamount to cell
rejuvenation. The Company is accomplishing these biological tasks
using compounds that have been accepted as safe for human
consumption and already approved by the FDA (Food and Drug
Administration) for human use. Industry trends have shown that
valid opportunities exist in the internet sales of nutraceuticals,
This is based on the Company's belief that with effective
marketing, astronomical opportunities will continue to exist in
internet sales of both pharmaceutical and nutraceutical products,
and that this multibillion dollar industry will continue to shift
towards the majority of its sales being executed online. Additional
information on the Company can be found at
www.symmetrytech.net
Safe Harbor Statement:
This press release may contain forward-looking statements,
within the meaning of Section 27 A of the 'Securities Act of 1933
and Sections 21E of the Securities Exchange Act of 1934, and are
subject to the safe harbor created by these sections. Any
statements that express or involve discussions with respect to
predictions, expectations, beliefs, plans, projections, objectives,
goals, assumptions or future events or performance are not
statements of historical fact and may be "forward looking
statements." Forward looking statements are based on expectations,
estimates and projections at the time the statements are made that
involve a number of risks and uncertainties which could cause
actual results or events to differ materially from those presently
anticipated. These forward-looking statements are only made as of
the date of the press release and Symmetry Technologies Inc. does
not undertake any obligation to publicly update such
forward-looking statements to reflect subsequent events or
circumstances.
CONTACT: Chad Reed
office@symmetrytech.net
Symmetry Technologies (CE) (USOTC:SMMR)
Historical Stock Chart
From Apr 2024 to May 2024
Symmetry Technologies (CE) (USOTC:SMMR)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Symmetry Technologies Inc (CE) (OTCMarkets): 0 recent articles
More News Articles